ArticleFrontiers in pharmacology2023

Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs.

Meng Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.